Multi-component assessment of chronic obstructive pulmonary disease: An evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets

npj Primary Care Respiratory Medicine

Volumn 26, Issue , 2016, Pages

  Jones, Rupert C ^a   Price, David ^b   Chavannes, Niels H ^c   Lee, Amanda J ^b   Hyland, Michael E ^d   Ställberg, Björn ^e   Lisspers, Karin ^e   Sundh, Josefin ^f   Van Der Molen, Thys ^g   Tsiligianni, Ioanna ^g  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF PLYMOUTH   (United Kingdom)

^e UPPSALA UNIVERSITY   (Sweden)

^f ÖREBRO UNIVERSITY   (Sweden)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE ASSESSMENT TEST; CLINICAL CHRONIC OBSTRUCTIVE LUNG DISEASE QUESTIONNAIRE; COHORT ANALYSIS; DISEASE EXACERBATION; DYSPNEA; FORCED EXPIRATORY VOLUME; GROUPS BY AGE; HEALTH CARE UTILIZATION; HEALTH STATUS; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NETHERLANDS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE ASSESSMENT; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SWEDEN; UNITED KINGDOM; COMPLICATION; DISEASE COURSE; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

AGED; COHORT STUDIES; DISEASE PROGRESSION; DYSPNEA; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PRIMARY HEALTH CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; SURVEYS AND QUESTIONNAIRES; SWEDEN; UNITED KINGDOM;

EID: 84963620455     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2016.10     Document Type: Article

References (32)

1. Wagner, E. H., Glasgow, R. & Davis, C. Quality improvement in chronic illness care: a collaborative approach. Jt Comm. J. Qual. Improv. 27, 63-80 (2003)
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD (2015) Available at http:// www. goldcopd. org/http://www. goldcopd. org/guidelines-global-strategy-for-diag nosis-management. html Accessed 10 November 2015
3. Dijk, W. D. et al. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir. Res. 12, 151 (2011)
4. Chavannes, N. H., Jones, R. C., Postma, D. S. & Rennard, S. Using COPD multidimensional indices in routine clinical practice: DOSE meets all criteria. Prim. Care. Respir. J. 21, 245-246 (2012)
5. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: management of adults with chronic obstructive pulmonary disease in primary and secondary care. NICE Guideline (CG101.) (2010)
6. Lange, P. et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am. J. Respir. Crit. Care Med. 186, 975-981 (2012)
7. de Torres, J. P. et al. Prognostic evaluation of COPD Patients: GOLD11 versus BODE and COPD comorbidity index COTE. Thorax 69, 799-804 (2014)
8. Han, M. K. et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 1, 43-50 (2013)
9. Puhan, M. A. et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 374, 704-711 (2009)
10. Ong, K. C., Lu, S. J. & Soh, C. S. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int. J. Chron. Obstruct. Pulmon. Dis. 1, 91-96 (2006)
11. Jones, R. C. et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease-The DOSE Index. Am. J. Respir. Crit. Care Med. 180, 1189-1195 (2009)
12. Sundh, J. et al. The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim. Care Respir. J. 21, 295-301 (2012)
13. Motegi, T. J. et al. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations. Int. J. Chron. Obstruct. Pulmon. Dis. 8, 259-271 (2013)
14. Rolink MvD, W., van den Haak-Rongen, S., Pieters, W., Schermer, T. & van den Bemt, L. Using the DOSE index to predict changes in health status of chronic obstructive pulmonary disease patients. Prim. Care Respir. J. 22, 169-174 (2013)
15. Hurst, J. R. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 363, 1128-1138 (2010)
16. Oga, T., Tsukino, M., Hajiro, T., Ikeda, A. & Nishimura, K. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 521-526 (2011)
17. Marin, J. M. et al. Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur. Respir. J. 42, 323-332 (2013)
18. Celli, B. R., Marin, J. M., Cote, C. G., Aguirre, A. & Macario, C. C. Prognostic assessment of patients with COPD. Lancet 374, 1885 (2009)
19. Soriano, J. B. et al. Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. CHEST 143, 694-702 (2013)
20. Department of Health. An outcomes strategy for people with chronic obstructive pulmonary disease (COPD) and asthma in England. London (2011) Gateway reference 16249
21. Donaldson, G. C., Seemungal, T. A., Bhowmik, A. & Wedzicha, J. A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57, 847-852 (2002)
22. Seemungal, T. A. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157(5 Pt 1): 1418-1422 (1998)
23. Soler-Cataluna, J. J. et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60, 925-931 (2005)
24. Bryden, C., Bird, W., Titley, H. A., Halpin, D. M. & Levy, M. L. Stratification of COPD patients by previous admission for targeting of preventative care. Respir. Med. 103, 558-565 (2009)
25. Make, B. J. et al. A score to predict short-term risk of COPD exacerbations (SCOPEX). Int. J. Chron. Obstruct. Pulmon. Dis. 10, 201-209 (2015)
26. Taylor, D. R. Risk assessment in asthma and COPD: a potential role for biomarkers? Thorax 64, 261-264 (2009)
27. Pascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. & Pavord, I. D. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir. Med. 3, 435-442 (2015)
28. Price, D. et al. Blood eosinophilia and the number of exacerbations in COPD patients. Eur. Respir. J. 44(Suppl 58) (2014)
29. Haughney, J., Gruffydd-Jones, K., Roberts, J., Hardwell, A. & McGarvey, L. The distribution of COPD in UK general practice using the new GOLD classification. Eur. Respir. J. 43, 993-1002 (2014)
30. Jones, R. C., Dickson-Spillmann, M., Mather, M. J., Marks, D. & Shackell, B. S. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir. Res. 9, 62 (2008)
31. Chavannes, N. et al. UNLOCK: Uncovering and noting long-term outcomes in COPD to enhance knowledge. Prim. Care Respir. J 19, 408 (2010)
32. Chavannes, N. H. et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim. Care Respir. J. 18, 171-176 (2009)